Research suggests that Endocyte's SMDCs can make CAR-T therapy safer; shares ahead 8% premarket [Seeking Alpha]
ENDOCYTE (ECYT)
Last endocyte earnings: 11/7 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investor.endocyte.com/investor-relations
Company Research
Source: Seeking Alpha
Thinly traded micro cap Endocyte (NASDAQ: ECYT ) perks up premarket on light volume in response to its announcement of new research supporting the value of its small molecule drug conjugates (SMDCs) in reducing the risk of excessive cytokine release in patients receiving CAR-T therapy. The data were presented at the American Association for Cancer Research in Washington, DC. Research conducted at Purdue University Center for Drug Discovery showed Endocyte's bi-specific SMDC adaptors can control the rate and extent of CAR T-cell activation by using a bispecific adaptor molecule to mediate engagement of the CAR T-cell with the cancer cell. The approach enables a universal CAR T-cell to bind and kill a cancer cell only when the bispecific adaptor creates a bridge between the two. Now read: Endocyte's NSCLC Drug: Any Residual Value? »
Show less
Read more
Impact Snapshot
Event Time:
ECYT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ECYT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ECYT alerts
High impacting ENDOCYTE news events
Weekly update
A roundup of the hottest topics